Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-23-000333
Filing Date
2023-08-29
Accepted
2023-08-29 14:04:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2854
  Complete submission text file 0001969223-23-000333.txt   4206
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-14656 | Film No.: 231220868
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 144